Qiagen shares rise on reports EQT is in advanced talks to buy the company
Bloomberg reports that EQT AB is in advanced talks to acquire Qiagen, with an offer above $50 a share. Qiagen shares gained about 6%.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Qiagen shares climbed about 6% after Bloomberg reported that Swedish buyout firm EQT AB is in advanced talks to acquire the European molecular testing company. Citing people familiar with the matter, the agency said EQT has submitted an offer of more than $50 a share. Rival private equity firm KKR & Co. has also made a bid.
The Qiagen board is due to meet this week to consider a possible transaction. Representatives for Qiagen, EQT and KKR declined to comment. The information is reported via Seeking Alpha.
why it matters
A completed deal would be a notable move in the diagnostics sector. Bloomberg stresses there is no certainty that talks will end in a sale to EQT or any other buyer, so the share gain rests on deal speculation and may not hold.
market impact
Qiagen shares: buyout speculation supports the stock, while the diagnostics sector watches how the talks end
tags
instruments
sources
- Qiagen jumps on report EQT in advanced talks to purchase the testing firm — Seeking Alpha, 20 October 2026 at 16:43 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗